newsfilter
← Latest News
GlobeNewswire·

Minerva Neurosciences to Report First Quarter 2023 Financial Results and Business Updates on May 15, 2023

BURLINGTON, Mass., May 08, 2023 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS)